Diamonds and Dogs
2/27/17
La La Land and La Jolla Pharma (LJPC) are big winners today. La Jolla Pharma is up 83% following positive phase 3 study results. La Jolla's drug showed positive treatment for catecholamine-resistant hypotension, or CRH which is a life-threatening condition in which blood does not properly flow to vital organs. The analyst at SunTrust upgraded the stock with a $57 target from $38. Not bad.
TSLA is down 4% today on a downgrade from Goldman Sachs. Tesla is now down 13% in the last four trading days following earnings and a wider than expected loss per share, but the automaker did announce that the mass-market electric Model 3 sedan is on track for initial production in July. Goldman lowered their price target on Tesla to $185 from $190 so it sounds like they were a bear on the stock for a while.
Diamonds and Dogs market commentary is a journal of daily observations on anything that happens to be of interest to our author. Obviously, our primary focus is the stock market and world economic events, but for this page we have no defined topics. We want this page to be dedicated to the interests, concerns, and possibly to the financial gain of our clients and friends. All comments contained herein are for informational purposes only, and should not be considered as a solicitation to buy or sell any security. The firm does not guarantee the accuracy or completeness of the information or make any warranties regarding results from it's usage.